Dr. Ross Cagan

Research Interests

cancer biology, drug development, rare genetic diseases

My laboratory works with a variety of collaborators to develop a drug development platform that combines Drosophila genetics with medicinal and computational chemistry. Further, we are using aspects of this platform in a fly-to-bedside trial. Our primary focus is cancer and rare genetic diseases. OOAC would provide an additional bridge between fly and patient by allowing rapid, patient-relevant testing of candidate therapeutics.

Collaboration Interests

We are looking to collaborate with mammalian systems and chemical biologists to develop new therapeutic leads and to explore the biology of cancer therapeutics.